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Abstract
Synthetic nitro musks are fragrant chemicals found in household and personal care products. The use of these
products leads to direct exposures via dermal absorption, as well as inhalation of contaminated dust and volatilized
fragrances. Evidence also suggests that humans are exposed to low doses of these chemicals through oral
absorption of contaminated liquids and foods. As these compounds are lipophilic, they and their metabolites, have
been found not only in blood, but also breast milk and adipose tissue. After personal use, these environmentally
persistent pollutants then pass through sewage treatment plants through their effluent into the environment.
Little is known about the biological effects in humans after such a prolonged low dose exposure to these
chemicals. While epidemiologic studies evaluating the effects of nitro musk exposures are lacking, there is limited
evidence that suggest blood levels of nitro musks are inversely related to luteal hormone levels. This is supported
by animal models and laboratory studies that have shown that nitro musks are weakly estrogenic. Nitro musks
exposure has been associated with an increased risk of tumor formation in mice. The evidence suggests that while
nitro musks by themselves are not genotoxic, they may increase the genotoxicity of other chemicals. However,
animal models for nitro musk exposure have proven to be problematic since certain outcomes are species specific.
This may explain why evidence for developmental effects in animals is conflicting and inconclusive. Given that
animal models and cell-line experiments are suggestive of adverse outcomes, further epidemiologic studies
are warranted.
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Introduction
Synthetic nitro musks are alkylated nitrobenzene deriva-
tives. These chemicals are an anthropogenic component
in fragrant compositions. They were synthesized in the
early 1900s as inexpensive substitutes for natural macro-
cyclic musks used in perfumes [1]. Nitro musks gener-
ally refer to the five most commercially relevant fragrant
compounds (Figure 1): ketone musk (4-tert-butyl-2,6-
dimethyl-3,5-dinitroacetophenone), musk ambrette (2,6-
dinitro-3-methoxy-4-tert-butyltoluene), musk moskene
(1,1,3,3,5-pentamethyl-4,6-dinitro-2H-indene), musk tibe-
tene (1-tert-butyl-3,4,5-trimethyl-2,6-dinitrobenzene) and
musk xylene (1-tert-butyl-,5-dimethyl-2,4,6-trinitroben-
zene). Musk moskene and musk tibetene have been pro-
hibited from use in fragrant products because of adverse
outcomes from structurally similar compounds [2]. Musk
ambrette has been discontinued from use because its con-
sumption was associated with hind limb weakness in rats
and observed neuropathologic changes in the brain, spinal
cord and peripheral nerves [3]. Ketone musk and musk
xylene continue to be used as additives in detergents, fab-
ric softener, household cleaning products and other fra-
grant non-cosmetic products with musk xylene being the
most widely used nitro musk [4].
In 2008, under the authority of the Registration, Evalu-
ation, Authorization and Restriction of Chemicals (REACH)
regulation, musk xylene was classified as a substance of high
concern with a very persistent, very bioaccumulative (vPvB)
designation. A restricted use warning was placed on musk
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grade easily, causing them to be highly stable and ubiquitous
in the environment [5].
Nitro musks have been largely replaced by polycyc-
lic musks due to banning of these compounds in sev-
eral countries [6,7]. However, nitro musks are still being
produced in China and India and used in non-cosmetic
compounds in the United States that have not been refor-
mulated. Given the environmental persistence and the
continued use of nitro musks even at a decreased level,
there are concerns for the effects of long-term exposure.
This overview is designed to evaluate the literature on ni-
tro musks and discuss areas for further research.
Background
Human exposures
The primary source of exposure to synthetic musks is
through exposure to scented personal care products or
scented household goods. In a report evaluating the con-
centrations of synthetic musks in personal care products
in China, Lu et al. found musk xylene in 19% of the
products and they found musk ketone in 57% of the
products tested. These products included hair care prod-
ucts, body washes, toilet soaps, skin lotions and make
up. The highest concentration of musk xylene was found
in skin lotions with a mean concentration of 0.16 ug/g
of lotion. The highest concentration of musk ketone was
found in hair care products with a mean concentration
of 8.12 ug/g of product [8].
The three main routes of exposure to nitro musks are
through inhalation, dermal absorption and ingestion.
Lu et al. [9] tested dust from a random sampling of
homes in China finding musk ketone in 98.7% of the
homes at a median concentration of 13.7 ng/g and musk
xylene at a median concentration of 11.8 ng/g in 86.4% of
the homes. This raises concern for inhalation of nitro
musks through residual dust in the home [9]. However,
human exposure to nitro musks via inhalation from the
environment has been found to be minimal suggesting
that inhalation from direct use is probably a more import-
ant exposure [10].
Dermal exposure to fragrances was thought to be an
important route of exposure to musk. However, evidence
suggests that absorption of dermally applied nitro musks
is low. In a study by Hawkins et al. [11] when musk ke-
tone and musk xylene were separately applied dermally
to the backs of seven participants, the study found that
after 6 hours, they were able to recover 86% of applied
musk ketone with only 0.49% found in the urine and less
than 0.01% in the feces and they were able to recover a
range of 90-94% of musk xylene with 0.2-0.3% excreted
in the urine and none found in the feces. Neither chemical
was found in the blood. Hutter et al. [12] reached similar
findings when they evaluated the association between der-
mal absorption through cosmetic use and blood levels of
synthetic musks. Lignell et al. [13] looked at the effect of
dermal absorption of nitro musks through perfume appli-
cation in lactating women. They found that perfume use
Figure 1 Structural formulas of the five most commercially relevant synthetic nitro musks.
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tone and musk xylene in breast milk. However, Eisenhardt
et al. [14] found that blood levels of nitro musk were
associated with use of cosmetics, in particular with per-
fume use, which would suggest an association with dermal
absorption but also could be due to inhalation. However,
it appears they did not control for strong predictors of
lipophilic chemical concentrations in the blood such as
age, number of children breastfed or Body Mass Index
when evaluating this relationship. This suggests that per-
cutaneous absorption might not be as significant as ini-
tially thought, and so should be controlled for in exposure
analyses but might not be as important of a route of
exposure.
Considering that most nitro musks have been replaced
by polycyclic musks in many products applied dermally,
oral exposure through contaminated water or food
might be a big contributor to nitro musk presence in the
blood, breast milk, and lymphocytes [4]. This is sup-
ported by a study performed by Riedel and Dekant [15]
in which both dermal and oral exposures to musk xylene
were assessed in 12 volunteers over a 96 hour exposure.
The percentage of dose administered found in plasma was
an order of magnitude greater for oral exposure when
compared with dermal exposure. Nitro musks have been
found at concentrations ranging from below the limit of
detection to 470 ng/g of lipid weight in freshwater fish
samples, a result of sewage runoff into aquatic systems.
Because of this consumption of contaminated fish may be
an important exposure to consider [16]. However, while
varying levels of nitro musks have been found in fish sam-
ples, Kafferlein and Angerer found that dietary intake of
fish, assessed by a food frequency questionnaire, was not
correlated with blood levels of nitro musks [1,17,18].
Most human studies involving nitro musks have
looked to assess the toxicokinetics of the chemicals once
the nitro musks are absorbed. Upon absorption by the
body, musk xylene can go through a reduction process
that produces nitro derivatives. One of these derivatives,
1-tert-butyl-3,5-dimethyl-4-amino-2,6-dinitrobenzene has
been shown to bind to hemoglobin and is a biotransform-
ation product that is often found in urine [19]. The half-
life of musk xylene ranges from 60-94 in the body [20].
This long half-life can be explained by a two com-
partment kinetic model where musk is either initially bio-
transformed by the body and excreted or distributed by
the blood into a second compartment, in this case, the
adipose tissue [15].
Nitro musks have a low range (4.3-4.9) of octanol-
water partition coefficients indicating that they are lipo-
philic [21]. In 1994, studies began finding the presence
of nitro musks in human adipose tissue and milk sam-
ples. Levels of nitro musks ranged from 0.01 to 0.22 mg/kg
of fat in adipose samples and 0.01-0.19 mg/kg of fat in milk
samples [22]. In a study performed in Massachusetts on
breast milk, Reiner et al. [23] found similar results with
ranges of nitro musks found between 0.02-0.238 mg/kg of
fat. Maternal age was not correlated with the levels of
musks in breast milk, which is not consistent with most
persistent organic pollutants. There was an inverse rela-
tionship between number of children breastfed previously
and breast milk concentration, which is to be expected
with lipophilic pollutants. However, this relationship was
not significant.
Musks in the environment
Although human use of household and personal care
products containing nitro musks is the primary route
of human exposure, it was the presence of these com-
pounds in environmental samples that originally drove
concern about the biological and environmental effects of
nitro musks in the 1980s. Yamagishi et al. [17] found their
presence in more than 80% of freshwater fish samples,
river water, and waste water taken from multiple sampling
stations on the Tama River and Tokyo Bay. Since then
nitro musks have been found in the biota and marine en-
vironments of the Baltic Sea, the North Sea, the Vlatava
River in Prague, and Lake Michigan in the U.S. [1,24,25].
Nitro musks are not easily degradable, which accounts
in part for their widespread presence in environmental
samples. Nonetheless when nitro musks make their way
from personal use settings and into wastewater, passage
through sewage treatment plants does appear to degrade
the nitro musks somewhat as by-products of nitro musks
have been found in sampled sewage treatment plant efflu-
ents [6]. However, sewage treatment plants only degrade
between 46-54% of the nitro musks that enter the plant
prior to releasing their effluent back into the environment
[7]. Therefore, even with such treatment, the potential for
environmental exposure remains. Furthermore, the bio-
transformation products of nitro musks created by the
sewage treatment process might also be of interest in risk
assessment. Biotransformation products of nitro musks
have been found in aquatic systems at higher concentra-
tions than the parent compound indicating that trans-
formed products of nitro musks are also environmentally
persistent [17,24,26].
Wastewater effluent has the ability to affect the con-
centrations of chemicals in surface water. This is of im-
portance when contaminated water sources are used to
supply water treatment plants or where they are used to
recharge groundwater. Herberer et al. [27] found that
some organic pollutants found in tap water were corre-
lated with the levels of surface water filtration and
intentional ground water replenishment in Berlin. In the
United States, recycled wastewater is currently used for
indirect potable reuse and non-potable reuse, meaning
reused water is not directly used for tap water. However,
Taylor et al. Environmental Health 2014, 13:14 Page 3 of 7
http://www.ehjournal.net/content/13/1/14a report put out by the National Committee on the
Assessment of Water Reuse as an Approach to Meeting
Future Water Supply Needs [28] declared that reused
water could be used to augment surface water supplies
which could be used for drinking water sources. This
would create a closed water system loop or a semi-closed
water system loop. This raises concern over how this will
affect the concentrations of nitro musks and other envir-
onmentally stable pollutants in drinking water. Evidence
suggests that areas that use closed or semi-closed looped
water replenishment systems see a gradual increase of
contaminant concentration over time. This effect is a re-
sult of low surface water flow and increased sewage efflu-
ent being added to surface waters [27,29].
An interesting secondary source of nitro musks to the
environment, specifically musk ketone, may be melting
glaciers. This was demonstrated in Lake Oberaar, a gla-
cier fed lake where spikes of persistent organic pollut-
ants were detected in glacier runoff [30]. This was even
seen for contaminants whose use had long been discon-
tinued. This suggests that even if nitro musk production
was discontinued there is still a potential for exposure.
The persistent nature of musks in the environment
has been well documented. Furthermore, a vast number
of people may be exposed to these chemicals. Although
a consensus has not been reached over the biological ef-
fects of the continuous, low-dose exposures humans
may experience, it is important that possible health out-
comes from such exposures to nitro musks are assessed.
Toxicity
Animal and laboratory studies of nitro musks have largely
focused on three main areas: developmental effects due to
perinatal and early childhood exposure, endocrine effects,
and carcinogenic effects. A summary of the studies used
in this overview can be found in Additional file 1.
Studies of developmental effects have focused on ad-
verse birth outcomes across species, such as the ability
to conceive and the viability of the embryos, and have
found conflicting results. Exposure of pregnant rats to
45 mg/kg/day of musk ketone or 200 mg/kg/day of
musk xylene, was not shown to have any adverse effect
on the embryo [31]. In zebrafish, musk ketone between
the levels of 0.1 and 10 mg/g of food/day was found to
reduce the body weight of spawning females up to 38%
and reduce the number of eggs/female/day up to 95%
[32]. Embryos that were exposed to musk ketone at
levels higher than 10 μg/l in the surrounding water had
decreased early life stage survival [32]. When embryos of
South African clawed frogs were exposed to 400 μg/l/
day of either musk ketone, musk xylene or musk mos-
kene in the surrounding water for 11 days, there was in-
creasing larvae mortality for each increasing day of
exposure [33].
Once the lipophilicity of nitro musks was recognized
there was general concern over the possible endocrine
modulating effects of these chemicals. This is because
many similar aromatic, lipophilic compounds have been
shown to have endocrine receptor binding capabilities
[34,35]. One of the first studies, investigating potential
endocrine effects, looked at the binding capability of
musk xylene, musk ketone, musk moskene and their de-
rivatives to the estrogen receptors in rainbow trout and
the South African clawed frog. There was no observed
binding of musk xylene, musk ketone or musk moskene
to the estrogen receptors in both species. However, there
was competitive binding of the estrogen receptors by
three of the derivatives, 4-NH2-musk xylene, 2-NH2-
musk xylene, and 2-NH2-musk ketone, in both species
after exposure to the chemicals for 20 hours at concen-
trations of 10
−6 to 10
−3 M in surrounding media, which
is well above environmentally relevant levels. The bind-
ing affinity of these derivatives were up to 375 times
lower than estradiol and up to 150 times lower than
bisphenol A [36].
Bitsch et al. [37] conducted an E-screen assay to detect
estrogenic activity using human MCF-7 breast cancer
cells exposed to 10 mmol of either musk xylene or musk
ketone per liter of test substance or 5 mmol of other
nitro musk derivatives per liter of surrounding media.
Estrogenic activity was confirmed by a significant in-
crease in the proliferation of human breast cancer cells
by 29% for musk xylene, by 97% for musk ketone and by
29% for p-amino-musk-xylene (a musk xylene derivative)
when compared to the negative control. This increased
proliferation was eradicated when the musks were added in
t h ep r e s e n c eo f1u m o l / Lo ft a m o x i f e n ,a na n t i - e s t r o g e n i c
drug, indicating that the musk effects were mediated, at
least partly by the estrogen receptor. However, relative
proliferation potency for the nitro musks in this assay was
approximately 30,000 times lower than estradiol.
Increased concern for the potential carcinogenic ef-
fects of nitro musks was raised by a study of Maekawa
et al. [38], which found that mice fed with food contain-
ing 0.075% or 0.15% musk xylene had up to three times
as many tumors upon post-mortem inspection than
control mice. Carcinogenicity studies after the Maekawa
study focused on examining whether these chemicals were
genotoxic. Multiple studies using various tests for geno-
toxicity in rats, E. coli PQ27 cells, human lymphocytes,
and human hepatoma cell lines indicated that nitro musks
were not genotoxic [39-41]. These results implied that
there were other processes occurring in vivo to promote
tumor genesis.
One potential pathway to explain this increase in
tumor genesis after exposure to nitro musks is that it
could be a result of nitro musks interaction with other
toxins to increase the potency of known genotoxicants.
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DNA damage, musk ketone, but not musk xylene,
was shown to increase the toxicity of benzo-a-pyrene,
2-aminoanthracene and aflotoxin B1 in rats when ex-
posed to levels higher than 10 mg of musk ketone per day
[42]. This was confirmed using a micro nucleus test on
musk ketone exposed human derived Hep G2 cells. When
the Hep G2 cells were exposed to 5–5000 ng/l of musk
ketone and 0.2 ug/ml of benzo-a-pyrene, no biological
interaction occurred. However, when the cells where ex-
posed to musk ketone 28 hours before the addition of
benzo-a-pyrene, there was a synergistic effect showing an
increase in the genotoxic effects of benzo-a-pyrene expos-
ure [43]. The enhanced effect of benzo-a-pyrene after
musk ketone exposure may be explained by the ability
of musk ketone and musk xylene, injected individu-
ally, to induce production of CYP-4501A2, CYP-4501A3,
and CYP-450IB2 which was initiated when rats were
injected at doses starting at 10 mg of each musk per kg of
body weight. These enzymes are produced in response to
exposure to xenobiotics in order to reduce or oxidize che-
micals in the body. This response is usually beneficial but
can sometimes have deleterious effects if the xenobiotic
becomes more reactive after its transformation [44,45].
In contrast, Schnell et al. [46] found that both musk
xylene and musk ketone inhibit the catalytic processes
of CYP4501A in carp, suggesting that nitro musk inter-
action with CYP450 is likely species-specific [44,45].
Another pathway for the promotion of tumor genesis
was proposed by Luckenbach and Epel [47]. They found
that musk xylene and musk ketone could inhibit the
effectiveness of multidrug efflux transporters in mar-
ine mussels. A major consequence of this inhibition is
loss of the cell’s ability to remove xenobiotics, includ-
ing known carcinogens, allowing them to remain in
the cell longer. The effects of an exposure to 2 hours
of synthetic musks took between 24 and 48 hours to
be reversed.
Health outcomes
There has been one case control study that has evalu-
ated possible health outcomes associated with nitro
musk exposure. This study by Eisenhardt et al. [14] ana-
lyzed the association between musk ketone and musk
xylene blood levels and endocrine and gynecological prob-
lems in premenopausal women at an endocrinological
outpatient clinic. They found that women presenting with
premenstrual syndrome had on average 24 ng musk ke-
tone per liter of blood higher than women who did not
present with premenstrual syndrome (p=0.014). They
also found that musk xylene levels were inversely associ-
ated with levels of the luteal phase hormones, progester-
one and estrogen (p=0.08). Women who presented as
being infertile had 23.5 ng/L higher serum levels of musk
xylene than those who had already been pregnant once
(p=0.045). However, given that nitro musks are lipophilic
the lower levels of musk xylene in fertile women can pos-
sibly be explained by elimination of nitro musk through
breast feeding. These findings are suggestive and may
indicate that nitro musks could be disruptors of the
hypothalamic-ovarian hormone pathway and further
research is necessary to evaluate this relationship.
Conclusion
The use of animal models and laboratory studies is im-
portant for the risk assessment process. However, it can
be difficult to extrapolate how these studies apply to typ-
ical everyday exposures of humans. The exposure con-
centrations of the nitro musks in the various animal
models addressed above ranged from 1 μl/L to 5000 μl/L.
Considering nitro musks have been found in aquatic sys-
tems at lower concentrations and that humans have sig-
nificantly more body mass than the animals being studied,
the studies may not be applicable to human nitro-musk
exposure. At the same time, many of these animal studies
involved short duration exposures. Although human ex-
posure is likely at lower doses, it also is likely to be long-
term. The animal studies do not address this exposure
scenario.
The body of literature supports the conclusion that
not only are we being exposed to nitro musks, we are
also bioaccumulating them and passing them on to our
offspring through breast milk and perinatal exposures.
While the animal studies do not address long-term low
dose effects, they do indicate that a particular area of
focus for health outcomes from nitro musk exposure
should be tumor genesis and cancer. While animal studies
were conflicting for potential developmental effects, this
lack of agreement indicates that more research needs to
be done in this field. Human endocrine effects have been
seen for nitro musk exposures; this indicates that more
studies need to be done in animals and humans at envir-
onmentally relevant exposure levels. In light of the evi-
dence, the precautionary principle should be taken into
account. This can be done through a reduction in the use
and production of products containing nitro musks.
Additional file
Additional file 1: Summary of nitromusk toxicity studies performed
in animals and human cell lines.
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